Processa Pharmaceuticals (PCSA) Short Interest Ratio & Short Volume $1.67 +0.01 (+0.60%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Processa Pharmaceuticals Short Interest DataCurrent Short Interest48,700 sharesPrevious Short Interest68,400 sharesChange Vs. Previous Month-28.80%Dollar Volume Sold Short$84,738.00Short Interest Ratio0.0 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares2,860,000 sharesFloat Size2,510,000 sharesShort Percent of Float1.94%Today's Trading Volume9,482 sharesAverage Trading Volume1,331,301 sharesToday's Volume Vs. Average1% Short Selling Processa Pharmaceuticals ? Sign up to receive the latest short interest report for Processa Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPCSA Short Interest Over TimePCSA Days to Cover Over TimePCSA Percentage of Float Shorted Over Time Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Processa Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202448,700 shares $84,738.00 -28.8%1.9%0 $1.74 6/30/202468,400 shares $153,216.00 -51.9%2.7%0.1 $2.24 6/15/2024142,200 shares $248,850.00 +532.0%5.7%0.1 $1.75 5/31/202422,500 shares $33,300.00 -52.6%0.9%0 $1.48 5/15/202447,500 shares $95,950.00 -91.6%1.9%0 $2.02 4/30/2024568,300 shares $1.24 million +199.7%24.8%0.4 $2.18 Get the Latest News and Ratings for PCSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 4/15/2024189,600 shares $287,244.00 +429.6%8.3%0.1 $1.52 3/31/202435,800 shares $84,667.00 -11.2%1.6%0 $2.37 3/15/202440,300 shares $88,257.00 -40.1%2.9%0 $2.19 2/29/202467,300 shares $165,558.00 -29.7%5.4%0 $2.46 2/15/202495,700 shares $232,551.00 -41.0%7.7%0.1 $2.43 1/31/2024162,100 shares $382,556.00 +1,721.4%12.5%0.1 $2.36 1/15/20248,900 shares $46,796.20 -98.0%0.7%0.1 $5.26 12/31/2023443,300 shares $148,328.18 +46.3%N/A0.2 $0.33 12/15/2023303,000 shares $216,645.00 -17.6%N/A0.1 $0.72 11/30/2023367,800 shares $235,392.00 +55.1%N/A0.2 $0.64 11/15/2023237,200 shares $93,456.80 +13.6%N/A0.1 $0.39 10/31/2023208,900 shares $73,323.90 +13.0%N/A0.1 $0.35 10/15/2023184,800 shares $88,704.00 +43.4%N/A0.1 $0.48 9/30/2023128,900 shares $32,250.78 -6.7%N/A1.2 $0.25 9/15/2023138,100 shares $53,168.50 +14.9%N/A1.8 $0.39 8/31/2023120,200 shares $37,742.80 +31.8%N/A1 $0.31 8/15/202391,200 shares $34,656.00 +11.6%N/A0.8 $0.38 7/31/202381,700 shares $35,948.00 -6.6%N/A0.7 $0.44 7/15/202387,500 shares $40,512.50 -28.7%N/A0.7 $0.46 6/30/2023122,700 shares $61,043.25 -32.6%N/A1 $0.50 6/15/2023182,000 shares $109,200.00 -9.6%N/A1.6 $0.60 5/31/2023201,300 shares $124,806.00 +3.2%N/A2.3 $0.62 5/15/2023195,000 shares $128,505.00 +0.5%N/A2.1 $0.66 4/30/2023194,000 shares $122,220.00 +18.7%N/A1.6 $0.63 4/15/2023163,500 shares $81,750.00 -12.3%N/A0.6 $0.50 3/31/2023186,400 shares $93,218.64 -41.7%N/A0.7 $0.50 3/15/2023319,700 shares $164,325.80 -14.3%N/A1.2 $0.51 2/28/2023372,900 shares $249,805.71 -15.8%N/A1.4 $0.67 2/15/2023442,800 shares $352,026.00 +94.5%N/A1.7 $0.80 1/31/2023227,700 shares $194,683.50 -1.6%2.0%0.9 $0.86 1/15/2023231,500 shares $289,375.00 -9.3%2.0%5.2 $1.25 12/30/2022255,300 shares $280,830.00 +124.7%2.2%6.3 $1.10 12/15/2022113,600 shares $214,704.00 +38.4%1.0%3 $1.89 11/30/202282,100 shares $155,948.95 +11.7%0.7%4.3 $1.90“Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. 11/15/202273,500 shares $151,410.00 -5.3%0.7%4.3 $2.06 10/31/202277,600 shares $164,512.00 +7.0%0.7%5.5 $2.12 10/15/202272,500 shares $160,950.00 -13.3%0.7%5.6 $2.22 9/30/202283,600 shares $188,936.00 +27.3%0.8%6.6 $2.26 9/15/202265,700 shares $170,820.00 +0.2%0.6%4.6 $2.60 8/31/202265,600 shares $180,400.00 -4.8%0.6%4.5 $2.75 8/15/202268,900 shares $224,614.00 -4.8%0.6%4.3 $3.26 7/31/202272,400 shares $224,440.00 -17.6%0.6%2.9 $3.10 7/15/202287,900 shares $296,776.77 -15.3%0.8%3.2 $3.38 6/30/2022103,800 shares $291,678.00 -5.3%0.9%3.3 $2.81 6/15/2022109,600 shares $283,864.00 -11.3%0.9%3.6 $2.59 5/31/2022123,500 shares $314,925.00 +31.9%1.1%3.6 $2.55 5/15/202293,600 shares $169,416.00 +19.7%0.8%2.8 $1.81 4/30/202278,200 shares $216,614.00 +8.0%0.7%2.6 $2.77 4/15/202272,400 shares $230,956.00 -9.1%0.6%2.2 $3.19 3/31/202279,600 shares $239,596.00 -21.2%0.7%2.5 $3.01 3/15/2022101,000 shares $349,460.00 +8.6%0.9%3 $3.46 2/28/202293,000 shares $356,190.00 -18.6%0.8%2.6 $3.83 2/15/2022114,300 shares $417,195.00 -5.4%1.0%2.9 $3.65 1/31/2022120,800 shares $446,960.00 +5.1%3.0%2.8 $3.70 1/15/2022114,900 shares $499,815.00 +18.5%2.8%2.6 $4.35 12/31/202197,000 shares $475,300.00 +11.9%2.4%2.2 $4.90 12/15/202186,700 shares $362,406.00 +7.4%2.1%1.7 $4.18 11/30/202180,700 shares $440,622.00 -11.8%2.0%1.5 $5.46 11/15/202191,500 shares $589,260.00 -2.5%2.3%1.5 $6.44 10/29/202193,800 shares $649,096.00 -16.4%2.3%1.6 $6.92 10/15/2021112,200 shares $879,648.00 +4.7%2.8%1.1 $7.84 9/30/2021107,200 shares $918,704.00 +15.4%2.6%1.1 $8.57 9/15/202192,900 shares $690,247.00 +17.6%2.3%1 $7.43 8/31/202179,000 shares $515,080.00 -4.9%2.2%0.8 $6.52 8/13/202183,100 shares $449,571.00 -28.7%2.3%0.9 $5.41 7/30/2021116,500 shares $696,670.00 -8.6%3.3%1.3 $5.98 7/15/2021127,500 shares $860,625.00 -7.9%3.6%2.6 $6.75 6/30/2021138,400 shares $1.13 million +107.8%3.9%2.6 $8.19 6/15/202166,600 shares $442,890.00 +8.1%1.9%0.9 $6.65 5/28/202161,600 shares $378,840.00 -8.1%1.7%0.9 $6.15 5/14/202167,000 shares $412,720.00 -8.7%1.9%0.9 $6.16 4/30/202173,400 shares $616,560.00 +15.2%2.1%0.8 $8.40 4/15/202163,700 shares $596,232.00 +17.7%1.5%0.8 $9.36 3/31/202154,100 shares $590,231.00 +21.0%1.5%0.7 $10.91 3/15/202144,700 shares $518,520.00 +329.8%1.3%0.7 $11.60 2/26/202110,400 shares $110,968.00 -14.1%0.3%0.2 $10.67 2/12/202112,100 shares $95,590.00 +157.5%0.3%0.2 $7.90 1/29/20214,700 shares $29,187.00 -44.1%0.1%0.1 $6.21 1/15/20218,400 shares $57,456.00 No Change0.2%0.3 $6.84 9/30/2020100 shares $900.00 No ChangeN/A0 $9.00 PCSA Short Interest - Frequently Asked Questions What is Processa Pharmaceuticals' current short interest? Short interest is the volume of Processa Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 48,700 shares of PCSA short. 1.94% of Processa Pharmaceuticals' shares are currently sold short. Learn More on Processa Pharmaceuticals' current short interest. What is a good short interest percentage for Processa Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.94% of Processa Pharmaceuticals' floating shares are currently sold short. Is Processa Pharmaceuticals' short interest increasing or decreasing? Processa Pharmaceuticals saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 48,700 shares, a decrease of 28.8% from the previous total of 68,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Processa Pharmaceuticals' float size? Processa Pharmaceuticals currently has issued a total of 2,860,000 shares. Some of Processa Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Processa Pharmaceuticals currently has a public float of 2,510,000 shares. How does Processa Pharmaceuticals' short interest compare to its competitors? 1.94% of Processa Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Processa Pharmaceuticals: Viracta Therapeutics, Inc. (3.53%), Vincerx Pharma, Inc. (1.36%), Synlogic, Inc. (0.16%), Conduit Pharmaceuticals Inc. (5.99%), Longeveron Inc. (50.00%), Apollomics, Inc. (0.09%), Indaptus Therapeutics, Inc. (0.24%), Aptorum Group Limited (0.08%), VBI Vaccines Inc. (1.08%), Aytu BioPharma, Inc. (6.87%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Processa Pharmaceuticals stock? Short selling PCSA is an investing strategy that aims to generate trading profit from Processa Pharmaceuticals as its price is falling. PCSA shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Processa Pharmaceuticals? A short squeeze for Processa Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PCSA, which in turn drives the price of the stock up even further. How often is Processa Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PCSA, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VIRX Short Squeeze VINC Short Squeeze SYBX Short Squeeze CDT Short Squeeze LGVN Short Squeeze APLM Short Squeeze INDP Short Squeeze APM Short Squeeze VBIV Short Squeeze AYTU Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PCSA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Processa Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Processa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.